Administration unapproved drug
Sponsors
Miyazaki Tomoyuki, Eiro Tsuyoshi, Asami Takeshi
Conditions
ARMSAdverse Childhood Experiences
Adverse Childhood ExperiencesAngelman SyndromeAutism spectrum disorderChronic pain
Chronic painLong COVIDPatients with depression,bipolar disorderSchizophrenia
Unknown Phase
A clinical trial to examine the distribution of [11C]K-2 in patients with autism spectrum disorder.
Active, not recruitingJPRN-jRCTs031190149
Start: 2020-02-18Target: 30Updated: 2026-06-29
A clinical trial to examine the distribution of [11C]K-2 in patients with depression and bipolar disorder.
Active, not recruitingJPRN-jRCTs031190150
Start: 2020-02-03Target: 60Updated: 2026-06-29
A clinical trial to investigate the relationship between [11C] K-2 and the presence or absence of onset after chronic observation of psychotic high risk cases
Active, not recruitingJPRN-jRCTs031190151
Start: 2020-10-28Target: 30Updated: 2026-06-29
A clinical trial to examine the distribution of [11C]K-2 in patients with schizophrenia
Active, not recruitingJPRN-jRCTs031190197
Start: 2020-02-10Target: 30Updated: 2026-06-29
Pathological elucidation study using AMPA-PET and GABA-PET for patients with Angelman syndrome
Active, not recruitingJPRN-jRCTs031210261
Start: 2021-08-19Target: 10Updated: 2026-06-29
Biomarker development study of pain quantification in patients with chronic pain using AMPA receptor density as an index
Active, not recruitingJPRN-jRCTs031210314
Start: 2021-12-06Target: 60Updated: 2026-06-29
A clinical trial to determine the distribution of AMPA receptor density in patients with persistent cognitive sequelae after COVID-19 disease.
Active, not recruitingJPRN-jRCTs031230306
Start: 2023-08-24Target: 30Updated: 2026-06-29
Exploratory study using [11C]K-2 to identify brain regions that contribute to acquiring mental resilience based on AMPA receptor density
RecruitingJPRN-jRCTs031230715
Start: 2024-06-10Target: 20Updated: 2026-06-29